ReutersShares of the Ltd. traded at Rs 952.5 on BSE at 10:57AM (IST) on Tuesday, up 1.29 per cent. The stock quoted a 52-week low price of Rs 737.9 and a high of Rs 1063.75.
Earlier in the day, the stock saw a gap up opening.
At the prevailing price, the stock traded at 10.44 times its trailing 12-month EPS of Rs 91.05 per share and 1.44 times its book value, as per BSE data.
A total of 26,088 shares changed hands on the counter till 10:57AM (IST). The stock commands a market value of Rs 55713.97 crore and is part of the Pharma - Indian industry.
The scrip has been an underperformer , up 17.71 per cent in the past one year in comparison with a 43.35 per cent gain in Sensex.
During the day, the stock moved between Rs 953.3 and Rs 938.25.
Promoter/FII Holding
Promoters held 48.86 per cent in the company as of 31-Mar-2021. FII and MF ownership in Aurobindo Pharma Ltd. stood at 24.37 per cent and 8.84 per cent, respectively.
Earlier in the day, the stock saw a gap up opening.
At the prevailing price, the stock traded at 10.44 times its trailing 12-month EPS of Rs 91.05 per share and 1.44 times its book value, as per BSE data.
Did you Know?
Stock score of Aurobindo Pharma Ltd moved down by 2 in 3 months on a 10-point scale.
View Latest Stock Report »A total of 26,088 shares changed hands on the counter till 10:57AM (IST). The stock commands a market value of Rs 55713.97 crore and is part of the Pharma - Indian industry.
The scrip has been an underperformer , up 17.71 per cent in the past one year in comparison with a 43.35 per cent gain in Sensex.
During the day, the stock moved between Rs 953.3 and Rs 938.25.
Promoter/FII Holding
Promoters held 48.86 per cent in the company as of 31-Mar-2021. FII and MF ownership in Aurobindo Pharma Ltd. stood at 24.37 per cent and 8.84 per cent, respectively.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.